The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The purpose of accreditation is to set quality practice standards and certify facilities that meet them, according to Dr. Harvey Neiman, ACR executive director. The peer-reviewed assessments include an evaluation of personnel qualifications, equipment performance, and image quality, as well as standards and protocols for quality assurance and quality control.
"The ACR is extremely proud to do its part to help ensure that our nation's veterans receive the highest quality healthcare available," Neiman said.
The college brings considerable experience to the assignment. About 200 radiation oncology facilities in the U.S. have either been accredited or are going through the ACR accreditation process. As with nongovernment facilities, the accreditation process for the VA services will involve both self-assessment and independent external expert audits, based on ACR guidelines and technical standards.
ACR accreditation requires that the physicians providing radiation therapy to patients meet specific education and training standards. It also mandates that the equipment be inspected regularly by qualified medical physicists and that the radiation therapists administering the treatments be appropriately certified.
In addition to radiation oncology, the ACR manages accreditation programs for MRI, CT, nuclear medicine, PET, diagnostic ultrasound, radiation oncology, stereotactic breast biopsy, mammography, and breast ultrasound. About 16,000 facilities have earned ACR accreditation, Neiman said.
For more information from the Diagnostic Imaging archives:
Proponents hail pass of Medicare bill as triumph for physicians, patients
FDA panel recommends adding stereotactic breast biopsy to quality standards program
Consultant describes how MRI services can meet accreditation deadline
New Study Finds Racial Disparities with Pre-Op Breast MRI and Positive Surgical Margin Rates
November 8th 2024In addition to a lower rate of preoperative breast MRI use, emerging research found that Black women with breast cancer who didn’t have a preoperative MRI had a higher positive surgical margin rate than White women with no preoperative MRI.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.